Exelixis
EXEL
#2073
Rank
NZ$12.36 B
Marketcap
$43.35
Share price
-2.83%
Change (1 day)
20.35%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: NZ$12.36 Billion

As of September 2024 Exelixis has a market cap of NZ$12.36 Billion. This makes Exelixis the world's 2073th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$12.36 B4.83%
2023NZ$11.79 B44.76%
2022NZ$8.14 B-3.51%
2021NZ$8.44 B-2.45%
2020NZ$8.65 B9.09%
2019NZ$7.93 B-9.7%
2018NZ$8.78 B-30.59%
2017NZ$12.66 B102.93%
2016NZ$6.24 B231.83%
2015NZ$1.88 B422.99%
2014NZ$0.35 B-73.89%
2013NZ$1.37 B34.51%
2012NZ$1.02 B24.5%
2011NZ$0.82 B-29.56%
2010NZ$1.16 B5.85%
2009NZ$1.10 B20.05%
2008NZ$0.91 B-21.45%
2007NZ$1.16 B-4.6%
2006NZ$1.22 B6.68%
2005NZ$1.14 B15.13%
2004NZ$0.99 B29.13%
2003NZ$0.77 B-14.82%
2002NZ$0.90 B-59.61%
2001NZ$2.24 B45.72%
2000NZ$1.54 B

End of Day market cap according to different sources

On Sep 18th, 2024 the market cap of Exelixis was reported to be:

NZ$12.36 Billion
by Yahoo Finance info icon info icon
NZ$12.36 Billion
by CompaniesMarketCap info icon info icon
NZ$12.36 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$140.91 B 1,039.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$234.38 B 1,795.40%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$486.09 B 3,830.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$162.99 B 1,218.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$289.14 B 2,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$646.48 B 5,127.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$272.49 B 2,103.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$56.63 M-99.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.84 B-93.18%๐Ÿ‡บ๐Ÿ‡ธ USA